https://medicine.ouhsc.edu/news Parent Page: News id: -1 Active Page: Newsid:22450

College News

Results of a Phase III clinical trial published recently in The Lancet show that oropharyngeal cancer patients receiving proton therapy kept their cancer under control just as well as patients receiving traditional radiation therapy, or photon therapy. Importantly, patients treated with proton therapy were more likely to be alive at the five-year mark of the study and suffered fewer side effects than those receiving photon therapy. The trial is considered the largest of its kind to compare the treatments.

Read more >

Cigarillos, a small type of cigar, have dramatically risen in popularity, particularly those that come in flavors, such as cherry or chocolate. Some state and local laws have banned all flavored cigars, and the Food and Drug Administration has announced its intention for a federal ban. In response, the tobacco industry has introduced “concept” flavors – products with ambiguous names like “Ocean Breeze” or “Jazz” with no explicit flavor name, thereby evading any bans and subverting regulations. Sales of concept cigarillos have increased in areas where bans on flavored cigarillos exist, suggesting consumers may be switching to these products.

Read more >

The Oklahoma Tobacco Settlement Endowment Trust (TSET) has awarded the University of Oklahoma a $25 million grant to help construct a new OU Health Stephenson Cancer Center facility in Tulsa, a project that will house the newly named TSET Clinical Research Center and significantly expand access to clinical trials and cancer care in the region.

Read more >

A new study from the University of Oklahoma suggests that small genetic differences in two proteins – previously known for their role in premature infants’ lungs – may also influence how their eyes develop, potentially affecting the risk of retinopathy of prematurity (ROP).

Read more >

The success of GLP-1 medications for treating Type 2 diabetes and obesity naturally leads to a related question: Do GLP-1 drugs affect cancer risk, which is often associated with obesity and Type 2 diabetes?

Read more >
13Last